Determining the etiologies of age-related clonal hematopoiesis (ARCH), a new biomarker of cancer and cardiovascular disease development: focus on the roles of inflammation and genetic predisposition.
Determining the etiologies of age-related clonal hematopoiesis (ARCH), a new biomarker of cancer and cardiovascular disease development: focus on the roles of inflammation and genetic predisposition.
确定年龄相关克隆造血（ARCH）的病因，这是癌症和心血管疾病发展的新生物标志物：重点关注炎症和遗传易感性的作用。
批准号：
390845
负责人：
Busque Lambert
金额：
$69.66万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2023-09-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aging is associated with the acquisition of small changes (mutations) in the genes of blood cells called Age-Related Clonal Hematopoiesis (ARCH). It seems benign as people have no abnormalities in their blood counts. However, ARCH is associated with a 10-
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C3i - Centre for commercialization of Cancer Immunotherapy
-
批准号：338079
-
项目类别：Operating Grants
-
资助金额：$766.02万
-
财政年份：2015
-
负责人：Busque Lambert
-
依托单位：
Relationship between clonal architecture of aging hematopoiesis and the risk of developing age-associated myeloid cancers.
-
批准号：305881
-
项目类别：Operating Grants
-
资助金额：$61.59万
-
财政年份：2014
-
负责人：Busque Lambert
-
依托单位：
海外基金
